Epigenomics AG

EANS-Voting Rights: Epigenomics AG
Release of a voting rights announcement according to article 26, section 1.1 WpHG (Securities Trading Act) with the aim of a Europe-wide distribution

--------------------------------------------------------------------------------
  Notification of voting rights transmitted by euro adhoc. The issuer is
  responsible for the content of this announcement.
-------------------------------------------------------------------------------- 
Person/company obliged to make the notification: 
----------------------------------- 
Name:    Federated Kaufmann Fund
Place:   Pittsburgh, PA
State:   USA 
Company data:
----------------------- 
Name:    Epigenomics AG
Address: Kleine Präsidentenstraße 1, 10178 Berlin
Place:   Berlin
State:   Deutschland 
Voting Rights: Release of a Voting Rights Notification Pursuant to § 26, para.
1 WpHG (German Securities Trading Act) with the Aim of an Europe-wide
Distribution 
Issuer: 
Epigenomics AG
Kleine Präsidentenstr. 1
10178 Berlin
Germany 
Voting Rights Notification: 
On 9 April 2010, Federated Investors Inc., Pittsburgh, PA, USA, in the name and
on behalf of the Federated Kaufmann Fund, Pittsburgh, PA, USA, made the
following notifications regarding the holding of voting rights held in
Epigenomics AG pursuant to § 21 para. 1 WpHG: 
On 6 April 2010 the voting rights in Epigenomics AG held by Federated Kaufmann
Fund fell below the 3 per cent thresholds of § 21 para. 1 WpHG and Federated
Kaufmann Fund held at this date 2.89 per cent (i.e. 1,275,180 shares with
voting rights of the 44,092,085 shares outstanding at that date) in Epigenomics
AG. 
Date of release: 12. April 2010 
Epigenomics AG
The Executive Board 
Contact: 
Epigenomics AG
Dr. Achim Plum
Senior Vice President Corporate Development
Tel.: +49 (0)30 24345 368
Fax: +49 (0)30 24345 555
Email: achim.plum@epigenomics.com 
end of announcement                               euro adhoc
-------------------------------------------------------------------------------- 

Further inquiry note:


Branche: Biotechnology
ISIN: DE000A0BVT96
WKN: A0BVT9
Index: Prime All Share, Technology All Share
Börsen: Frankfurt / regulated dealing/prime standard
Berlin / free trade
Hamburg / free trade
Stuttgart / free trade
Düsseldorf / free trade
München / free trade
Original-Content von: Epigenomics AG, übermittelt durch news aktuell

Themen in dieser Meldung


Das könnte Sie auch interessieren: